These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22967413)

  • 1. [Clinical significance of the Wilms' tumor 1 mRNA expression in childhood myelodysplastic syndrome].
    Cheng YF; Zhang LP; Liu YR; Qin YZ; Wu J; Liu GL
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jul; 33(7):536-40. PubMed ID: 22967413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Wilms' tumor-1 gene expression in myelodysplastic syndrome and its changes in the process of myelodysplastic syndrome transforming into acute leukemia].
    Yang JK; Li JL; Li ZG; Li ZG; Liu PJ; Li JY; Lü HR; Deng Q; Lin XM; Cao JN
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Sep; 15(9):557-9. PubMed ID: 12971856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significant correlation between the degree of WT1 expression and the International Prognostic Scoring System Score in patients with myelodysplastic syndromes.
    Cilloni D; Gottardi E; Messa F; Fava M; Scaravaglio P; Bertini M; Girotto M; Marinone C; Ferrero D; Gallamini A; Levis A; Saglio G;
    J Clin Oncol; 2003 May; 21(10):1988-95. PubMed ID: 12743153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wilms' tumor 1 message and protein expression in bone marrow failure syndrome and acute leukemia.
    Iwasaki T; Sugisaki C; Nagata K; Takagi K; Takagi A; Kojima T; Ito M; Nakamura S; Naoe T; Murate T
    Pathol Int; 2007 Oct; 57(10):645-51. PubMed ID: 17803653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wilms' tumor 1 mRNA expression: a good tool for differentiating between myelodysplastic syndrome and aplastic anemia in children?
    Zuo Y; Cheng Y; Zhang L; Qin Y; Luo H
    Hematology; 2019 Dec; 24(1):480-486. PubMed ID: 31210595
    [No Abstract]   [Full Text] [Related]  

  • 6. [Expression of WT1 and PRAME gene in bone marrow and peripheral blood samples of patients with myelodysplastic syndrome].
    Lu D; Qin YZ; Li LD; Shi HX; Lai YY; Liu YR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):370-6. PubMed ID: 24763007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-time PCR quantification of major Wilms' tumor gene 1 (WT1) isoforms in acute myeloid leukemia, their characteristic expression patterns and possible functional consequences.
    Kramarzova K; Stuchly J; Willasch A; Gruhn B; Schwarz J; Cermak J; Machova-Polakova K; Fuchs O; Stary J; Trka J; Boublikova L
    Leukemia; 2012 Sep; 26(9):2086-95. PubMed ID: 22430637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wilms' tumor-1 transcript in peripheral blood helps diagnose acute myeloid leukemia and myelodysplastic syndrome in patients with pancytopenia.
    Yamauchi T; Matsuda Y; Takai M; Tasaki T; Hosono N; Negoro E; Ikegaya S; Takagi K; Kishi S; Yoshida A; Urasaki Y; Ueda T
    Anticancer Res; 2012 Oct; 32(10):4479-83. PubMed ID: 23060576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes.
    Tamaki H; Ogawa H; Ohyashiki K; Ohyashiki JH; Iwama H; Inoue K; Soma T; Oka Y; Tatekawa T; Oji Y; Tsuboi A; Kim EH; Kawakami M; Fuchigami K; Tomonaga M; Toyama K; Aozasa K; Kishimoto T; Sugiyama H
    Leukemia; 1999 Mar; 13(3):393-9. PubMed ID: 10086730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of WT1 gene in patients with myelodysplastic syndrome and acute leukemia].
    Lu Y; Jin J; Xu WL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Aug; 12(4):464-6. PubMed ID: 15363132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia: a wide range of WT1 expression levels, its impact on prognosis and minimal residual disease monitoring.
    Boublikova L; Kalinova M; Ryan J; Quinn F; O'Marcaigh A; Smith O; Browne P; Stary J; McCann SR; Trka J; Lawler M
    Leukemia; 2006 Feb; 20(2):254-63. PubMed ID: 16341043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of WT1 mRNA and anti-WT1 antibody levels in peripheral blood in patients with myelodysplastic syndromes.
    Tamura H; Dan K; Yokose N; Iwakiri R; Ohta M; Sakamaki H; Tohyama K; Kondo A; Hyodo H; Nakamura K; Yamashita T; Elisseeva OA; Oka Y; Oji Y; Sugiyama H; Ogata K
    Leuk Res; 2010 Aug; 34(8):986-90. PubMed ID: 20031209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WT1 gene expression: useful marker for minimal residual disease in childhood myelodysplastic syndromes and juvenile myelo-monocytic leukemia?
    Bader P; Niemeyer C; Weber G; Coliva T; Rossi V; Kreyenberg H; Gerecke A; Biondi A
    Eur J Haematol; 2004 Jul; 73(1):25-8. PubMed ID: 15182334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell receptor Vbeta CDR3 oligoclonality frequently occurs in childhood refractory cytopenia (MDS-RC) and severe aplastic anemia.
    de Vries AC; Langerak AW; Verhaaf B; Niemeyer CM; Stary J; Schmiegelow K; van Wering ER; Zwaan CM; Beishuizen A; Pieters R; van den Heuvel-Eibrink MM
    Leukemia; 2008 Jun; 22(6):1170-4. PubMed ID: 18323803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WT1 gene expression lowered by IL-12 In vitro in peripheral blood mononuclear cells from patients with leukemia or myelodysplastic syndromes.
    Pan L; Zhang XJ; Niu ZY; Suo XH; Zhang JY; Yang L; Liu XJ; Qiao SK; Dong ZR; Ohno R
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun; 14(3):501-7. PubMed ID: 16800930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Significance of dynamic detection of WT1 expression on monitoring minimal residual disease in leukemia patients following allogeneic bone marrow transplantation].
    Gu WY; Chen ZX; Hu SY; Zhu J; Wang ZL; Yan F; Wang W; Cen JN; Shen HL; Qian J
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(7):444-7. PubMed ID: 15854547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of Wilms' Tumor 1 Gene in Bone Marrow of Patients with Myelodysplastic Syndrome and Its Clinical Significance].
    Pan DQ; Zhao WS; Yin CX; He H; Lin R; Zhao K; Ye JY; Liu QF; Dai M
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1501-1507. PubMed ID: 36208256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The level of bone marrow WT1 message is a useful marker to differentiate myelodysplastic syndromes with low blast percentage from cytopenia due to other reasons.
    Baba M; Hata T; Tsushima H; Mori S; Sasaki D; Turuta K; Hasegawa H; Ando K; Sawayama Y; Imanishi D; Taguchi J; Yanagihara K; Tomonaga M; Kamihira S; Miyazaki Y
    Intern Med; 2015; 54(5):445-51. PubMed ID: 25758068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [WT1 gene expression in myelodysplastic syndrome and its clinical implication].
    Huang J; Jin J; Xu WL
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 35(2):132-5. PubMed ID: 16610077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparisons of clinical features of chronic aplastic anemia and myelodysplastic syndrome in children].
    Hao JJ; Qiu YN; Zhou DF; Xiao Y; Liu Q; Jin RM
    Zhongguo Dang Dai Er Ke Za Zhi; 2011 Nov; 13(11):867-9. PubMed ID: 22099192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.